Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Post by Nomoreshells4meon May 12, 2020 8:42am
110 Views
Post# 31015752

Rising tides lift all boats

Rising tides lift all boats
I'm here to make money. LBL can/will make money. I'm not fooling myself that somehow Guy and Chad are some movers and shakers, pioneering stem cell therapy. Fact: Look at Pluristem and Mesoblast's last news releases. They are going into Phase 2 trials in hospitals with 150 and 300 patients respectively. All patients are intubated. They are proving that this treatment works in real time in life and death situations. In contrast: LBL will be doing a clinic trial of patients who are no longer on respirators. This will be done by a respiratory therapist on 10 patients. So what LBL is trying to prove is that Amnioboost can help the survivors of COVID-19. Once Pluristem and Mesoblast undoubtedly prove it works then the mear fact that LBL offers a stem cell based approach should lift its share price. Guy talked a Big game and after 2 months went back to square one. Now he's talking s Big game 2.0 when he hasn't delivered on the 1st. I'm not buying the hype for a minute but once Pluristem and Mesoblast have finished their trials I'm sure LBL can ride the wave for a double of the 7 cents they're currently at. Jmo
<< Previous
Bullboard Posts
Next >>